The segmentation of the Ubiquitin Proteasome Drug Market is becoming increasingly granular as new therapeutic applications are discovered. While hematological malignancies remain the primary focus, there is a burgeoning interest in using proteasome modulation for solid tumors, including breast, lung, and colorectal cancers. This diversification is essential for the long-term viability of the...
Portuguese (Brazil) 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt